Abiopharma

Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease

Grant Thornton Advisors Standardizes MSSP Operations on CrowdStrike Falcon Complete, Replacing Legacy MDR with Agentic MDR

Sidus Spaces LizzieSat® Completes Vibration Testing Ahead of Expected Fall 2026 Launch

Cooper Standard Recognized as a Finalist for IndustryWeeks Best Plants Awards

NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure

GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth

MMA Terminates Equity Line of Credit, Confirms No Drawdowns Occurred from the Facility

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

Axe Compute Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute